A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemia

A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a type of blood cancer caused by the abnormal accumulation of malignant plasma cells. In this study, we generated CLL iPSCs (KUMi004-a) using the Sendai virus, confirming pluripotency. Also, it can differentiate into three primary germ layers. We expect this cel...

Full description

Bibliographic Details
Main Authors:	Ji-Hea Kim, Ka-Won Kang, Byung-Hyun Lee, Young Park, Hwa Jung Sung, Byung-Soo Kim
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506122000174

Similar Items

Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patient
by: Ji-Hea Kim, et al.
Published: (2021-08-01)

Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemia
by: Ji-Hea Kim, et al.
Published: (2021-08-01)

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma
by: Ji-Hea Kim, et al.
Published: (2022-12-01)

Generation of a human induced pluripotent stem cell line KUMi006 from a patient with multiple myeloma
by: Ji-Hyeon Hong, et al.
Published: (2022-05-01)

Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3
by: Ji-Hea Kim, et al.
Published: (2022-08-01)

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium
by: Seung-Jin Lee, et al.
Published: (2020-08-01)

Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium
by: Seung-Jin Lee, et al.
Published: (2020-10-01)

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2022-05-01)

Generation of three human induced pluripotent stem cell sublines (UCLAi004-A, UCLAi004-B, and UCLAi004-C) for reproductive science research
by: Erica C. Pandolfi, et al.
Published: (2021-07-01)

An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual
by: Lijing Wang, et al.
Published: (2021-05-01)

Generation of an integration-free induced pluripotent stem cell line (JTUi004-A) from an otosclerosis patient
by: Hongmin Wu, et al.
Published: (2022-05-01)

Generation of an induced pluripotent stem cell line (SYSUSCi004-A) from a patient with Infantile Malignant Osteopetrosis
by: Rui Fang, et al.
Published: (2024-04-01)

Historical aspects of the use in medicine kumis
by: R. R. Kudayarova, et al.
Published: (2010-10-01)

Establishment of a controlled induced pluripotent stem cell line SDPHi004-A from a healthy male donor
by: Ziwen Feng, et al.
Published: (2023-09-01)

Generation of human induced pluripotent stem cell line (XWHNi004-A) from a male with APOE gene mutation
by: Pin Wang, et al.
Published: (2024-06-01)

Generation of a X-linked juvenile retinoschisis patient-derived induced pluripotent stem cell line ZOCi004-A
by: Linyan Zhang, et al.
Published: (2022-12-01)

Generation of an induced pluripotent stem cell line SYSUi-004-A from a child of microcephaly with TYW1 mutations
by: Chuanbo Sun, et al.
Published: (2020-05-01)

Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors
by: Eddy Quelennec, et al.
Published: (2020-10-01)

Insertion of a FLAG-tag sequence at the end of exon 9 of the TBX5 gene in three induced pluripotent stem cell lines (DHMi004-A-4, DHMi004-A-5, DHMi004-A-6) by CRISPR/Cas9 technology
by: Harald Lahm, et al.
Published: (2024-02-01)

Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents
by: Ka-Won Kang, et al.
Published: (2020-10-01)

Kumi-uchi from the Kaze no Ryu perspective
by: Luis Nogueira Serrano
Published: (2012-07-01)

CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)
by: Ji-Hea Kim, et al.
Published: (2023-11-01)

The grip dispute (kumi-kata ) in judo: A scoping review
by: Daniel Brandão Kashiwagura, et al.
Published: (2022-01-01)

Generation of an induced pluripotent stem cell line (SHETi004-A) from a Chinese Han child with left bundle branch block
by: Tingxia Wang, et al.
Published: (2023-12-01)

Generation of induced pluripotent stem cell line (VRISGi004-A) from a healthy female donor by reprogramming erythroid progenitor cells
by: Thi-Hoa Luong, et al.
Published: (2024-04-01)

Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage
by: Eris Bidollari, et al.
Published: (2018-04-01)

Establishment and characterization of an induced pluripotent stem cell line CPGHi004-A from peripheral blood mononuclear cells of a healthy adult
by: Junhao Deng, et al.
Published: (2022-03-01)

Generation of a human induced pluripotent stem cell line YCMi004-A from a patient with dilated cardiomyopathy carrying a protein-truncating mutation of the Titin gene and its differentiation towards cardiomyocytes
by: Sun-Ho Lee, et al.
Published: (2022-03-01)

Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration
by: Kazuma Kamata, et al.
Published: (2020-05-01)

Senyawa Bioaktif Daun Kumis Kucing (Orthosiphon stamineus)
by: Surahmaida Surahmaida, et al.
Published: (2019-06-01)

Generation of four induced pluripotent stem cell lines (FHUi003-A, FHUi003-B, FHUi004-A and FHUi004-B) from two affected individuals of a familial neurohypophyseal diabetes insipidus family
by: Satoru Yoshida, et al.
Published: (2020-10-01)

Induced pluripotent stem cell (iPSC) line MLi-004A derived from a patient with recessive dystrophic epidermolysis bullosa (RDEB)
by: Sandra Ropret, et al.
Published: (2021-08-01)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2021-06-01)

Assessment of the nutritional value and environmental safety of mare’s milk and kumis
by: M. M. Saukenova, et al.
Published: (2022-04-01)

Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1)
by: Shekhar Singh, et al.
Published: (2023-12-01)

Generation of a human induced pluripotent stem cell line from a patient with dent disease
by: Xianying Fang, et al.
Published: (2023-09-01)

Kumis treatment in the steppe regions as a promising direction of tourist nature management
by: Sviatokha Natalia, et al.
Published: (2020-01-01)

Generation of one human induced pluripotent stem cell line (XACHi004-A) with heterozygous mutation of RYR2 gene from an atrial fibrillation patient
by: Yafei Zhou, et al.
Published: (2022-12-01)

Generation of human induced pluripotent stem cell lines SPPHIi003-A and SPPHIi004-A from two patients with sporadic Alzheimer’s disease in Southwestern China
by: Li Chen, et al.
Published: (2022-10-01)

Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease
by: Valeria Lucchino, et al.
Published: (2021-05-01)